Miquel Triana Iglesias

dblp:326/4089 · DBLP profile ↗
← Back
1ranked-venue papers
0as first author
1since 2021 · last 2022
—ORCID · none

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 61% Computational science and engineering · 30% Medical and health informatics · 9%

Topics — the 4 heaviest of 4, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › biomarker discovery
clinical biomarker discovery
0.612022
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression · Bioinform. 2022
Bioinformatics and computational biology › multi-omics data integration
omics data integration
0.612022
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression · Bioinform. 2022
Computational science and engineering › scientific machine learning
symbolic regression
0.612022
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression · Bioinform. 2022
Medical and health informatics
precision medicine
0.212022
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression · Bioinform. 2022

Methods — techniques the papers use, named apart from their topics

symbolic regression · 0.6feature selection · 0.6
YearPublicationVenuePosition
2022 Identifying interactions in omics data for clinical biomarker discovery using symbolic regression
abstract
MOTIVATION: The identification of predictive biomarker signatures from omics and multi-omics data for clinical applications is an active area of research. Recent developments in assay technologies and machine learning (ML) methods have led to significant improvements in predictive performance. However, most high-performing ML methods suffer from complex architectures and lack interpretability. RESULTS: We present the application of a novel symbolic-regression-based algorithm, the QLattice, on a selection of clinical omics datasets. This approach generates parsimonious high-performing models that can both predict disease outcomes and reveal putative disease mechanisms, demonstrating the importance of selecting maximally relevant and minimally redundant features in omics-based machine-learning applications. The simplicity and high-predictive power of these biomarker signatures make them attractive tools for high-stakes applications in areas such as primary care, clinical decision-making and patient stratification. AVAILABILITY AND IMPLEMENTATION: The QLattice is available as part of a python package (feyn), which is available at the Python Package Index (https://pypi.org/project/feyn/) and can be installed via pip. The documentation provides guides, tutorials and the API reference (https://docs.abzu.ai/). All code and data used to generate the models and plots discussed in this work can be found in https://github.com/abzu-ai/QLattice-clinical-omics. SUPPLEMENTARY INFORMATION: Supplementary material is available at Bioinformatics online.
Niels Johan Christensen, Samuel Demharter, Meera Vieira Machado, Lykke Pedersen, Marco Salvatore, Valdemar Stentoft-Hansen, Miquel Triana Iglesias
Bioinform.7